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Of 500 patients who had a modified Fontan operation at
this institution between 1973 and 1987, 54 (33 boys and 21
girls) were <4 years old. This retrospective study related
preoperative clinical and hemodynamic data to subsequent
survival. Twenty patients <4 years old had tricuspid
atresia, 13 had double inlet ventricle and 21 had other
complex heart defects. There were 14 early deaths «30
days after operation) and 6 late deaths.
Multivariate analysis of survival for the entire group of
500 patients revealed the following factors to be signifi-
cantly associated with poorer survival: absence of tricuspid
The natural history of patients with a functional single
ventricle is poor (1,2). A surgically created systemic to
pulmonary artery shunt may reduce cyanosis secondary to
decreased pulmonary blood flow. A pulmonary artery band
may delay development of irreversible pulmonary vascular
obstructive changes and improve life expectancy (3-7).
However, mixing of the pulmonary and systemic venous
return persists and results in chronic hypoxemia, polycythe-
mia and a risk of systemic embolization. Increased pressure
or volume load of blood imposed on the functioning single
ventricle may contribute to myocardial failure. The Fontan
operation allows separation of pulmonary and systemic
venous return, eliminating cyanosis, hypoxemia and polycy-
themia and reducing ventricular volume load.
Modifications of the Fontan procedure are applicable to
patients with a wide spectrum of morphologic types of
functional single ventricle (8-11). Previously, we reported
our experience with the modified Fontan operation for
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atresia (p =0.011), asplenia (p < 0.001), age <4 years at
operation (p =0.042), atrioventricular valve dysfunction
(p =0.017), early calendar year of operation (p < 0.001)
and the presence of either one or more of the following: left
ventricular ejection fraction <60%, mean pulmonary ar-
tery pressure >15 mm Hg and pulmonary arteriolar resis-
tance >4 U'm2 (p < 0.001).
On the basis of this study of 500 patients, age <4 years
at operation appears to be an independent risk factor for
poorer survival after the modified Fontan operation.
(J Am Coil CardioI1990,'15:429-35)
tricuspid atresia and double inlet ventricle (12), pulmonary
atresia and intact ventricular septum (13), the asplenia and
polysplenia syndromes (14), patients without preoperative
sinus rhythm (15) and adult patients (16). All of these studies
included patients who did not fulfill the original selection
criteria for the Fontan operation (17). The purpose of this
investigation was to assess the specific risk of young age at
operation and its effect on survival after the modified Fontan
operation.
Methods
Study patients. Clinical and hemodynamic data from 500
consecutive patients (310 male and 190 female) who had a
modified Fontan operation at the Mayo Clinic between
October 1973 and January 1987 were recorded. Pertinent
data were abstracted from clinic records, and additional
follow-up information was obtained from correspondence
with primary care physicians and through questionnaires
sent to the patients (18). Among these patients, 54 children
(33 boys and 21 girls) had had the modified Fontan operation
before completing their fourth year of life. Of these 54
patients, 1 was <1 year old, 2 were between 1 and 2 years
old, 15 were between 2 and 3 years old and 36 were between
3 and 4 years old.
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Table 1. Preoperative Cardiac Diagnoses in 500 Patients Who Had
a Modified Fontan Operation
Age (yr)
<4 4 to 15 2:16
(n = 54) (n = 340) (n = 106)
Diagnosis No. % No. % No. %
Tricuspid atresia 20 37 104 31 40 38
Univentricular heart 13 24 103 30 40 38
Complex single 21 39 I33 39 26 24
ventricle
p =0.063 (by chi-square test for association between age and diagnosis, 4
degrees of freedom).
A subgroup of34 of these 54 patients <4 years old had
the operation on an entirely elective basis. Their overall
preoperative clinical course had been stable and, because
they were deemed suitable candidates for the Fontan oper-
ation, we elected not to defer the operation or to offer a
conventional palliative operation. A second subgroup of the
54 patients consisted of 20 patients who had the operation on
a nonelective, semiurgent basis because other forms of
treatment seemed inadequate to prevent a worsening clinical
course. Some of these patients had congestive heart failure,
complicating intracardiac or vascular morphologic features,
or previous unsuccessful palliative operations. The reason to
proceed with the Fontan operation was to provide these
patients with a chance for improved quality of life and,
possibly, life expectancy.
All patients had preoperative cardiac catheterization ei-
ther at the referring medical center or at the Mayo Clinic.
The cardiac diagnoses are detailed in Tables 1 and 2.
Statistical analysis. Statistical analysis included Fisher's
exact test, chi-square test of association for comparing
proportions, Wilcoxon rank-sum test, Kaplan-Meier sur-
vival curves, log-rank tests and Cox's proportional hazards
general linear model for assessing multivariate relations
between survival and risk factors (19-22). For the survival
analysis, the date of the Fontan operation was used as time
zero. All deaths that occurred after the initiation ofoperation
Table 3. Distribution of Risk Factors in 500 Patients Who Had a
Fontan Operation
Age (yr)
<4 4 to 15 2:16
(n = 54) (n = 340) (n = 106)
p
Factor No. % No. % No. % Value
Non-age risk factors
I) Sinus rhythm 2 22 6 14 13 0.018
absent
2) Abnormal systemic 14 26 65 19 12 II 0.057
venous drainage
3) Mean PA pressure 32 59 175 51 56 53 NS
>15 mm Hg
4) Rp >4 U·m2 2 4 8 2 0 0 NS
5) PA size <60% of 0 0 2 I I I NS
normal
6) LVEF <60% 9 17 85 25 31 29 NS
7) AV valve 7 13 10 3 13 12 NS
malfunction'
8) PA stenosis 12 22 82 24 18 17 NS
One or more of no. 3, 36 67 214 63 68 64 NS
4,6,7
'Moderate or severe insufficiency preoperatively or necessity for valve
repair or replacement. AV = atrioventricular; LVEF = left ventricular
ejection fraction; PA = pulmonary artery; Rp = pulmonary arteriolar resis-
tance.
were considered in the survival analysis irrespective of
whether they occurred intraoperatively, during the postop-
erative hospitalization or after hospitalization. The SAS
statistical software system was used throughout (22). Only
two-tailed p values were used.
The variables evaluated for their association with sur-
vival included age at operation, age <4 years at operation,
absence of sinus rhythm, abnormal systemic venous drain-
age, mean pulmonary artery pressure> 15 mm Hg, pulmo-
nary arteriolar resistance >4 U·m2, main pulmonary artery
size <60% of normal, left ventricular ejection fraction
<60%, moderate or severe insufficiency of or the need to
repair or replace an atrioventricular (AV) valve, pulmonary
artery stenosis, type ofcardiac lesion, asplenia and polysple-
nia and calendar year of operation.
p = 0.071 (by chi-square test for association between age and splenic
status, 4 degrees of freedom).
Table 2. Distribution of Patients With Asplenia or Polysplenia
Among 500 Patients Who Had a Modified Fontan Operation
4 to 15
(n = 340)
No.
Results
Preoperative status. A comparison of the preoperative
status of patients <4, 4 to 15 and;::: 16 years old at the time
of operation is detailed in Tables 1 through 4. Preoperative
status was based on the non-age-related risk factors sug-
gested by Choussat et al. (17). With the exception ofabsence
of sinus rhythm, which occurred less frequently in younger
patients (p = 0.018), the other risk factors (Table 3) and the
cumulative numbers of risk factors (Table 4) were distrib-
uted similarly among the three age groups.
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Table 4. Distribution of Total Number of Risk Factors in 500
Patients Who Had a Modified Fontan Operation
Table 5. Clinical Status of 54 Patients Having a Modified Fontan
Operation at Age <4 Years
Age (yr) Patients (no.)
Figure 2. Kaplan-Meier actuarial survival curves for patients <4
years old who had a modified Font~n operation. !here were 34
patients in the elective group and 20 III the nonelective group.
For patients <4 years old, complete follow-up informa-
tion was available on 22 of the 30 hospital survivors from the
elective subgroup and 8 of the 10 survivors from the non-
elective subgroup (Table 5). During the mean follow-up
period of 2.8 years (range 2.5 months to 8 years) for the
elective subgroup and of 2 years (range 1.5 months to 5.7
years) for the nonelective subgroup, there were three late
deaths in each subgroup (Fig. 2). Of these six late deaths,
three were from heart failure. Of the three patients who died
from heart failure, one had associated protein-losing enter-
opathy and pulmonary embolus, one had associated sepsis
and disseminated intravascular coagulation and one had
brain death. Afourth patient died of respiratory failure after
a cerebrovascular accident, a fifth patient died of pneumo-
nia; the cause of death of the sixth patient is unknown.
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(n = 20)
4
30
22
8
3
2*
4
4t
3
Elective
(n = 34)
Hospital deaths
Hospital survivors
Follow-up data available
No current follow-up data
Late deaths (>30 days postop)
Reoperations
Fluid retention
Dyspnea on exertion
Arrhythmias
Cardiac medications
Digitalis II 4 15
Diuretic drugs 8 3 II
Afterload reduction 5 I 6
Subjective improvement 17 5 22
*Pacemaker insertion in one patient and relief of conduit obstruction in
the other. tone patient living at high altitude requires oxygen therapy. Postop
= postoperatively.
<4 4 to 15 ~16
(n = 54) (n = 340) (n = 106)
No. of
Risk Factors* No. % No. % No. %
0 II 20 85 25 28 26
I 22 41 117 34 36 34
2 12 22 80 24 23 22
3 6 II 40 12 13 12
~4 3 6 18 5 6 6
Meant 1.43 1.39 1.37
*See Table 3 for definitions of risk factors. t = not significant.
Operative details. All operations were performed with
extracorporeal circulation, low flow and hypothermia. The~e
was no significant difference in the total bypass or aortic
cross-clamp time between patients <4 and patients >4 years
old at operation. Forty-three of the 54 patients <4 years old
had a direct right atrial to pulmonary artery anastomosis,
and 9 patients had a right atrial to right ventricular outflow
tract conduit (2 with incorporation of a valve). Two patients
had bilateral superior venae cavae, each connected to the
ipsilateral pulmonary artery. Twelve patients needed com-
plex rerouting of venous return by intraatrial baffles or
conduits (23).
Results of the operation for patients <4 years old. Four-
teen patients (26%) died at operation or in the early postop-
erative course. Of these 14 patients, 3 died at operation, 8
within the first week and 3 between 8 and 60 days after
operation. This early mortality rate was considerably lower
in the elective subgroup (4 deaths in 34 patients [12%]) than
in the nonelective subgroup (10 deaths in 20 patients [50%])
(p < 0.0001). The only patient with asplenia in the elective
group and the three patients with asplenia in the nonelective
group died. There were two patients with polysplenia in the
nonelective group, one of whom died. The operative mor-
tality rate for three consecutive 5 year periods comparing
patients <4 years old with the remainder of the patients is
shown in Figure 1.
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Figure 1. Operative mortality rate for th~ee consecutive 5 ~ear
periods for 500 patients who had a modified Fontan operatIOn.
Numbers above columns represent number of patients.
432 BARTMUS ET AL.
MODIFIED FONTAN OPERATION IN CHILDREN
JACC Vol. 15. No.2
February 1990:429-35
100
20
Years
100
80
o~
.~ ~ 50 ;,4 yr~.~.g~40n: rI) <4 r
20 P=O.OO9
B 0 0 4
Years
Figure 3. Kaplan-Meier actuarial survival curves for patients with A)
one or fewer non-age-related risk factors (there were 266 patients
~4 years old and 33 patients <4 years old), or B) two or more
non-age-related risk factors (there were 180 patients ~4 years old
and 21 patients <4 years old).
Among the 19 patients from the elective group who had
complete follow-up information and were alive at the last
evaluation, 17 were in improved condition. Four patients,
however, continue to have fluid retention, and two of these
rated their general condition as unchanged from their pre-
operative status. All five long-term survivors from the non-
elective group who had complete follow-up information are
reported to have significant improvement.
Operative and postoperative survival and predictors of
mortality (analysis of 500 patients). Overall survival was
worse for patients <4 years old at operation and those with
heterotaxia, absence of sinus rhythm, preoperative AV
valve insufficiency (moderate or severe) or the need for AV
valve repair or replacement and those with one or more of
the following risk factors: mean pulmonary artery pressure
> 15 mm Hg, pulmonary arteriolar resistance >4 U'm2, left
ventricular ejection fraction <60% and AV valve dysfunc-
tion (Table 6). Overall survival was better for patients with a
diagnosis of tricuspid atresia and worse for patients with
complex lesions. Survival improved with more recent calen-
dar year of operation (Table 6).
For patients who had none or only one of the eight
non-age-related risk factors listed in Table 3, overall sur-
vival was not detectably different for 33 patients operated on
at <4 years of age than for the 266 operated on at age :2:4
years (Fig. 3, Table 7). The 1 and 4 year survival rates were
73% and 73%, respectively, for patients <4 years and 85%
and 78%, respectively, for older patients.
For patients with more than one adverse risk factor,
survival was significantly poorer (p = 0.(08). Survival rates
at I and 4 years postoperatively were 54% and 47%, respec-
tively, for the 21 patients <4 years old and 77% and 68%,
respectively, for the 180 older patients. Also, overall sur-
vival rate was significantly poorer (p = 0.(03) for the 36
patients <4 years old than for the 282 older patients who had
one or more of the following risk factors: mean pulmonary
artery pressure> 15 mm Hg, pulmonary arteriolar resistance
>4 U'm2, left ventricular ejection fraction <60% and AV
valve dysfunction.
Discussion
The modified Fontan operation offers excellent definitive
palliation for most patients with functional single ventricle,
providing improved quality of life and increased exercise
tolerance (24-26). The original selection criteria for a low
risk Fontan procedure described by Choussat et al. (17)
included a lower age limit of4 years. As experience with this
operation increased, several surgeons conducted successful
operations in children <4 years old and even in infants (27).
The surgical mortality rate for this group of patients, how-
ever, has been consistently higher than that for older pa-
tients (28,29). Previously, young age was suggested to be an
independent risk factor for poorer operative outcome (30). It
was implied that smaller anatomic structures in this age
group contributed to increased technical difficulties at oper-
ation. Also, there was concern that increased pulmonary
vascular reactivity after cardiopulmonary bypass in these
young patients might contribute to an increased periopera-
tive mortality rate (31).
Effect of young age on operative survival: comparison with
other studies. Recently, however, several investigators have
suggested that young age at operation is not an independent
risk factor for survival after the Fontan operation. StelIin et
al. (32) reported the results of the Fontan operation for 35
consecutive patients who ranged in age from 8 months to 20
years (median age 3.4 years). For patients <4 years of age at
the time of operation, the mortality rate was 15%, and for
patients :2:4 years of age at operation, the mortality rate was
13%. Twenty of their patients were <4 years of age and 15
were :2:4 years at operation. On the basis ofa similar survival
rate, the authors concluded that age did not have an inde-
pendent effect on survival. Unfortunately, it is difficult to
determine from the data presented whether or not the
patients <4 years of age and the patients :2:4 years of age
were comparable relative to other risk factors for survival
after a Fontan operation. In addition, because of the rela-
tively small number of patients studied, a significant effect of
age at operation on survival may have gone undetected.
Mayer et al. (33) reported their experience with 167
consecutive patients undergoing the Fontan operation from
1973 to 1985. Forty-four of their patients were <4 years of
lACC Vol. 15, No.2
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Table 6. Assessment of Risk Factors in Relation to Survival After a Modified Fontan Operation in
500 Patients
Survival (%)
No. of Atl At4
p Value
Factor Patients Year Years Univariate Multivariate
I) Age (yr) 0.011 0.042
<4 54 61 56
2:4 446 80 73
2) Calendar year of operation 0.003 <0.001
(as a continuum)
3) Lesion <0.001
Tricuspid atresia 0.007 0.001
Present 164 85 82
Absent 336 75 67
Univentricular heart NS
Present 156 82 73
Absent 344 77 71
Complex <0.001 NS
Present 180 69 63
Absent 320 83 76
4) Heterotaxia <0.001
Present 49 54 45
Absent 451 81 74
Asplenia <0.001 <0.001
Present 23 39 39
Absent 477 81 73
Polysplenia 0.036 NS
Present 26 68 54
Absent 474 79 72
5) Sinus rhythm 0.012 NS
Absent 37 62 52
Present 463 80 73
6) Systemic venous drainage <0.001 NS
Abnormal 91 65 55
Normal 409 81 75
7) PA architecture NS NS
Abnormal 112 81 69
Normal 388 77 72
8) Mean PA pressure (mm Hg) 0.001 NS
Abnormal (>15) 263 73 64
Normal (';;15) 237 84 79
9) Rp (U.m2) 0.047
Abnormal (>4) 10 70 37
Normal (';;4) 490 78 72
10) LVEF (%) NS
Abnormal «60) 125 80 77
Normal (2:60) 375 78 70
11) AV valve <0.001 0.017
Abnormal' 54 54 47
Normal 446 81 74
12) For no. 8, 9, 10 and II <0.001 <0.001
2:1 present 318 74 65
All absent 182 86 80
'Moderate or severe insufficiency preoperatively or necessity for valve repair or replacement. - = variables not
included in the multivariate modeling because they were redundant given the other variables considered. Other
abbreviations as in Table 3.
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Table 7. Survival of 500 Patients Who Had a Modified
Fontan Operation
Age <4 Yr Age ~4 Yr
Survival (%) Survival (%) Log-Rank
No. 1 Yr 4 Yr No. 1 Yr 4 Yr p Value
No. of risk factors
0 11 91 91 113 88 83 NS
1 22 64 64 153 82 73 NS
2 12 33 33 103 72 57 0.002
3 6 53 82 70
2:4 3 24 58 52
Cumulative risk factors
~1 43 54 47 333 77 68 0.008
~2 21 44 29 180 73 62 0.008
~3 9 77 74 64
oto 1 33 73 73 266 85 78 NS
oto 2 45 62 62 369 81 74 0.024
oto 3 51 61 55 422 81 74 0.005
age and 26 (59%) survived. Multivariate analysis revealed
that pulmonary arteriolar resistance, pulmonary artery dis-
tortion and a left-sided morphologic mitral valve had inde-
pendent negative effects on survival. Earlier year of opera-
tion also had a negative effect on survival. Age, however, did
not have an independent effect. Mayer et al. (33) also found
that survival for patients with no known risk factors was
similar to that for patients who had only one recognized risk
factor. We found that moderate or significant AV valve
insufficiency and the need to repair the systemic AV valve
were significant risk factors. In contrast to the study by
Mayer et al. (33), we did not find pulmonary artery distortion
and pulmonary arteriolar resistance to be significant inde-
pendent predictors of survival. However, in the present
study, we treated pulmonary arteriolar resistance as a cate-
goric variable, using 4 U·m2 as the break point. Mayer et al.
(33) examined pulmonary arteriolar resistance from 0 to
0.99, from 1to 1.49, from 1.5 to 1.99 and >2 U·m2• We found
earlier age at operation to be a risk factor. It is unclear why
young age at operation was an independent risk factor in our
study, but not in that by Mayer et al. (33). Perhaps the
difference in sample size (167 in their study and 500 in our
study) accounts for this difference.
Kirklin et al. (34) assessed the effect of ventricular
hypertrophy, age and date ofoperation on survival after the
Fontan operation. These investigators studied 102 patients
who underwent operation between 1975 and 1985. They
found that young age was a risk factor for early postopera-
tive death, but that this risk was neutralized by recent date of
operation. They also found that "important" left-sided AV
valve incompetence was a significant independent risk factor
for death early after operation. These investigators offered
insight into the effect of variation of ventricular morphology
and underlying lesion on survival after this operation. On the
basis of their study, ventricular hypertrophy rather than
ventricular morphology and underlying anatomy was a risk
factor. The results of the present study are comparable with
those of Kirklin et al. (34). We also identified earlier calendar
year of operation as an independent risk factor for mortality.
In addition, the presence of moderate or severe AV valve
insufficiency or the need for operative repair of the AV valve
was an independent risk factor for mortality in our study as
well. Although we did not examine ventricular hypertrophy
as an independent predictor of mortality or survival, we did
find that the presence oftricuspid atresia was an independent
predictor for better survival. According to the study by
Kirklin et al. (34), this resulted, presumably, from the
presence of lesser degrees of ventricular hypertrophy in
patients with tricuspid atresia than in those with univentric-
ular heart or other complex lesions.
Kirklin et al. (34) pointed out that age was an independent
predictor of mortality early in their study, but in the later
years of their study, the risk of young age at operation was
neutralized by recent date of operation. Although the 500
patients in our study represent a very large cohort, it is a
relatively early experience with this operation at our institu-
tion. In contrast to the study by Kirklin et al. (34), age <4
years at operation remains a significant independent predic-
tor of poorer survival in our study. However, survival of
patients with no or one adverse risk factor was not detect-
ably different between patients who had operation when they
were <4 years old and those who were 2:4 years old.
Other important risk factors. We found that mean pulmo-
nary artery pressure> 15 mm Hg, abnormal systemic venous
drainage and pulmonary artery stenosis amenable to surgical
correction were univariately significant risk factors for mor-
tality. Although pulmonary arteriolar resistance >4 U·m2
and pulmonary artery size <60% of predicted also were not
found to be independent risk factors, very few patients in our
cohort violated these criteria (Table 3). This, no doubt,
represents preoperative application of these criteria to the
selection of patients undergoing this operation. Lack of a
statistically significant effect of these variables on survival in
this study does not imply that they are unimportant.
Asplenia was an independent riskfactor for poor survival
in this study. Humes et al. (14) previously reported results of
the modified Fontan operation for patients with asplenia and
polysplenia at the Mayo Clinic. Although in the early expe-
rience mortality was high in these two groups of patients,
operative mortality has declined considerably more recently.
Caveats of study design. There is an inherent problem in
determining the effect of age at operation on survival using
retrospective analysis as previous investigators (32-34) and
we have done. Given the substantial mortality rate that may
occur before a Fontan operation, patients who survive
beyond 4 years of age without operation likely are inherently
different from those who do not survive. The latter group,
presumably, is a higher risk group. In retrospective studies
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such as this one, observing comparable survival rates for
younger and older patients is not, inherently, a basis for
using age as a selection criterion for operation. The ideal
study design to determine the effect of young age at opera-
tion on survival would require random allocation of similarly
aged patients to operation or nonoperation.
Conclusions. According to our study of 500 patients, age
<4 years at operation appears to be an independent risk
factor for survival after the modified Fontan operation.
However, in a select subgroup of patients with one or fewer
risk factors, the survival of patients <4 years of age at
operation was not detectably different from that of older
patients.
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